ELV Elevance Health, Inc.
Elevance Health, Inc. (ELV) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $910.6K.
Where they traded
Last open-market purchase: July 17, 2026 , by PERU RAMIRO G .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| BOUDREAUX GAIL 2 fills | President and CEO | Buy | 2,725 | $367.79 | $1.0M | 171,976 | |
| PERU RAMIRO G | Director | Buy | 1,000 | $366.05 | $366.1K | 10,908 | |
| Penczek Ronald W | CAO & Controller | Sell | 369 | $403.16 | $148.8K | 3,740 −9% of holding | |
| Dixon Robert L JR | Director | Sell | 151 | $401.77 | $60.7K | 10,734 −1.4% of holding | |
| Penczek Ronald W | CAO & Controller | Sell | 1,531 | $403.13 | $617.2K | 4,109 −27.1% of holding | |
| SCHULMAN AMY W | Director | Sell | 26 | $287.50 | $7.5K | 218 −10.7% of holding | |
| Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 3,196 | $284.92 | $910.6K | 11,791 −21.3% of holding | |
| COLLIS STEVEN H | Director | Buy | 3,000 | $289.84 | $869.5K | 3,639 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.